Concepedia

Collin M. Blakely

CM

61

Publications

7.8K

Citations

36

H-Index

1998

Active since

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Dana-Farber Cancer Institute

University of Colorado Denver

University of California San Diego

Collin M. Blakely is an author at University of California, San Francisco specializing in medicine, cancer therapeutics, and oncology.

ORCID

Top concepts

Publications per year

1998–2025

61

Publications

61

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares et al. · The Lancet Oncology · 2019 · 1.7K citations · Full text

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Ashley Maynard, Caroline E. McCoach, Julia Rotow et al. · Cell · 2020 · 666 citations · Full text

Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation

Michael Gale, Collin M. Blakely, Bart Kwieciszewski et al. · Molecular and Cellular Biology · 1998 · 599 citations · Full text

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers

Collin M. Blakely, Thomas B.K. Watkins, Wei Wu et al. · Nature Genetics · 2017 · 566 citations · Full text

, , +10

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Apar Kishor Ganti, Billy W. Loo, M. Bassetti et al. · Journal of the National Comprehensive Cancer Network · 2021 · 431 citations · Full text

Rows per page

1–5 of 61